1Lila Assiff, Michael R Pollock, Patricia Manzi,et al. Health Economics in the Canadian pharmaceutical industry [J].Pharmacoeconomics, 1999, 16(6):669-678.
2Naoki Ikegami, Michael Drummond, Shunichi Fukuhara ,et al. Why has the use of Health Economic Evaluation in Japan lagged behind that in other developed countries[J]?Pharmacoeconomics, 2002, 20(Suppl2):2.
